International Cooperation
Mabpharm Limited is a leader in the research and development of antibody drugs and has always been committed to developing innovative drugs that bring health and hope to patients worldwide. We have already expanded, and continue to seek further expansion of, our development opportunities in China and international markets by partnering with global partners. We are committed to building long-term, stable, and mutually beneficial partnerships. We sincerely invite global partners to join us in opening a new chapter in the international sales of antibody drugs.
Our antibody drug products, known for their efficacy, safety, and stability, have gained widespread recognition in both domestic and international markets. Through strict quality control and adherence to Good Manufacturing Practices (GMP) certification standards, we ensure that each batch meets the highest quality standards, providing reliable treatment options for patients worldwide.
We offer comprehensive services, including R&D support, production, supply, and marketing, tailoring collaborative solutions for each partner. Whether you are a start-up company seeking rapid entry to emerging markets or an established pharmaceutical company looking for innovative drug resources, we are committed to providing you with full support and assistance.
CRDMO Cooperation
Mabpharm Limited's unique CRDMO business model provides a one-stop service from R&D to production, lowering the R&D threshold, improving R&D efficiency, and delivering more innovative treatment solutions to patients. As a technology-driven and customer-centric company, we look forward to collaborating with our partners to further advance the CRDMO industry.
We provide the end-to-end services, from drug development to commercial production services, including process development, analytical methods, and large-scale drug production. With our advanced technology platform and extensive project experience, we can help partners accelerate time-to-market for new drugs, shorten the R&D cycle, reduce risks, and ensure drug quality and stability.
We adopt a 'customized R&D and customized production' model, performing technology transformation and process optimization based on our partners' needs. We provide customized production services ranging from kg to ton-scale, and by continuously scaling up producting and increasing capacity, we further reduce production costs to meet the growing demands of our partners.
